Local Institution - 0109
Montreal, Quebec H4J 1C5
1 studies enrolling now · 3 studies all time
What they study most
Advanced Renal Cell Carcinoma (RCC), Lung Cancer, Various Advanced Cancer
Studies at this site
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now
- An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer — Completed
- An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers — Completed